Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | Transitional endoplasmic reticulum ATPase homolog | 0.0619 | 1 | 0.5 |
Trypanosoma cruzi | Valosin-containing protein, putative | 0.0587 | 0.9326 | 0.5 |
Trichomonas vaginalis | spermatogenesis associated factor, putative | 0.0619 | 1 | 1 |
Echinococcus multilocularis | transitional endoplasmic reticulum atpase | 0.0256 | 0.232 | 0.1979 |
Brugia malayi | valosin containing protein | 0.0363 | 0.4584 | 1 |
Mycobacterium ulcerans | ATPase | 0.0371 | 0.4742 | 0.5 |
Toxoplasma gondii | cell division protein CDC48CY | 0.0619 | 1 | 1 |
Entamoeba histolytica | transitional endoplasmic reticulum ATPase, putative | 0.0587 | 0.9326 | 0.5 |
Trypanosoma brucei | Valosin-containing protein | 0.0587 | 0.9326 | 0.5 |
Toxoplasma gondii | cell division protein CDC48AP | 0.0371 | 0.4742 | 0.0000097958 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.0256 | 0.232 | 0.1979 |
Loa Loa (eye worm) | hypothetical protein | 0.0363 | 0.4584 | 1 |
Plasmodium vivax | cell division cycle protein 48 homologue, putative | 0.0587 | 0.9326 | 1 |
Leishmania major | Transitional endoplasmic reticulum ATPase, putative,valosin-containing protein homolog | 0.0587 | 0.9326 | 0.5 |
Mycobacterium tuberculosis | Putative conserved ATPase | 0.0371 | 0.4742 | 0.5 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.0587 | 0.9326 | 0.9296 |
Loa Loa (eye worm) | vesicle-fusing ATPase | 0.0363 | 0.4584 | 1 |
Giardia lamblia | AAA family ATPase | 0.0371 | 0.4742 | 0.5 |
Plasmodium falciparum | cell division cycle protein 48 homologue, putative | 0.0587 | 0.9326 | 0.5 |
Brugia malayi | vesicle-fusing ATPase | 0.0363 | 0.4584 | 1 |
Echinococcus multilocularis | transitional endoplasmic reticulum atpase | 0.0619 | 1 | 1 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.0619 | 1 | 1 |
Entamoeba histolytica | cdc48-like protein, putative | 0.0587 | 0.9326 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 4.4668 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.7157 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 31.6228 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.